Improved patient recruitment for phase IIb/phase III clinical trials. more accurate resource estimates.
The main goals of late-stage clinical development are to show efficacy, safety, and cost-effectiveness. It corresponds to confirmatory investigations in Phases 2b and 3. In larger clinical investigations, the product is examined frequently in comparison to the treatment “gold standard” or standard-of-care (SoC), if any.
We work with you to identify the ideal sites, most experienced researchers, and patient enrollment populations. You can work with investigators who are more likely to assist you in achieving your patient enrollment targets right away because of our patented informatics capabilities. Beyond clinical recruitment, we assist you with cycle time optimization, supply chain requirements detection, and improved budget management.
Not all people fit into one size.
You want the best staff possible for your studies, not just any experts. With regard to your unique study demands, we offer a seasoned project management staff with pertinent scientific and clinical skills. Additionally, our P3 (predictive, proactive, preventative) Operating Platform gives you peace of mind knowing that your projects will be completed on schedule and within budget while maintaining high quality.
Out of pocket, out of mind.
The budget for your entire study may be nearly entirely made up of investigator out-of-pocket expenses. We have worldwide mechanisms in place to guarantee effective, prompt, and accurate billing, which helps you more than 90% of the time stay within +/-3% of your allocated budget. This lessens the chance of unexpected events affecting your ROI.
A skilled end-to-end collaborator is essential when the stakes are high.
Before the objective of regulatory approval is in sight, you must negotiate a global labyrinth of patient populations, practice patterns, and regulatory regulations, often along with languages and time zones. Your drug’s future is at stake. It’s difficult and calls for a variety of specialized resources. We provide a full range of clinical phase IIb/III services to maintain the integrity of your trial and increase ROI.